Sandro Javier Bedoya-Pacheco

Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil

Maurício Naoto Saheki, Marcelo Rosandiski Lyra, Sandro Javier Bedoya-Pacheco et al. · PLoS ONE · 2017 · 32 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

MONTENEGRO SKIN TEST AND AGE OF SKIN LESION AS PREDICTORS OF TREATMENT FAILURE IN CUTANEOUS LEISHMANIASIS

Liliane de Fátima Antônio, Aline Fagundes, Raquel de Vasconcellos Carvalhães de Oliveira et al. · Revista do Instituto de Medicina Tropical de São Paulo · 2014 · 31 citations · Full text

Medicine, Dermatology, Infectious Diseases +14

PANCREATIC TOXICITY AS AN ADVERSE EFFECT INDUCED BY MEGLUMINE ANTIMONIATE THERAPY IN A CLINICAL TRIAL FOR CUTANEOUS LEISHMANIASIS

Marcelo Rosandiski Lyra, Sônia Regina Lambert Passos, Maria Inês Fernandes Pimentel et al. · Revista do Instituto de Medicina Tropical de São Paulo · 2016 · 28 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Endemic Tegumentary Leishmaniasis in Brazil: Correlation between Level of Endemicity and Number of Cases of Mucosal Disease

Sandro Javier Bedoya-Pacheco, Maria Helena de Araújo-Melo, Cláudia Maria Valete‐Rosalino et al. · American Journal of Tropical Medicine and Hygiene · 2011 · 25 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +17

Sporotrichoid leishmaniasis: a cross-sectional clinical, epidemiological and laboratory study in Rio de Janeiro State, Brazil

Lívia Martins Veloso de Carvalho, Maria Inês Fernandes Pimentel, Fátima Conceição‐Silva et al. · Revista do Instituto de Medicina Tropical de São Paulo · 2017 · 24 citations · Full text

Veterinary Medicine, Dermatology, Infectious Diseases +12